Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly

Area of Science:

• Genetics
• Cardiology
• Neurology

Background:

• The apolipoprotein E (APOE) genotype is a significant genetic risk factor for dementia, Alzheimer's disease, and cardiovascular disease (CVD).
• APOE has three alleles: e2, e3, and e4, with e3 being the most common globally.
• The APOE e4 allele is associated with increased risk of CVD outcomes and higher low-density lipoprotein cholesterol levels.

Purpose of the Study:

• To review recent research on the relationship between APOE genotype and cardiovascular disease (CVD) in the elderly.
• To explore the vascular mechanisms through which APOE influences CVD risk in older populations.

Main Methods:

• Literature review of recent scientific research.
• Analysis of studies focusing on APOE, CVD, and vascular mechanisms in elderly populations.

Main Results:

• The APOE e4 allele is linked to increased CVD risk, particularly in conjunction with elevated cholesterol levels.
• Few studies have specifically investigated the impact of APOE on CVD in older individuals, highlighting a research gap.
• Emerging research suggests specific vascular pathways affected by APOE influencing CVD pathogenesis in the elderly.

Conclusions:

• Understanding the role of APOE in CVD is crucial, especially for the aging population.
• Further research is needed to elucidate the precise vascular mechanisms of APOE in elderly CVD.
• Targeting APOE-related pathways may offer novel strategies for preventing and treating CVD in older adults.